Lexeo Therapeutics, Inc. (LXEO) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $397.0K | -17.5% |
| 2024 | $481.0K | +318.3% |
| 2023 | $115.0K | -82.9% |
| 2022 | $672.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $397.0K | -17.5% |
| 2024 | $481.0K | +318.3% |
| 2023 | $115.0K | -82.9% |
| 2022 | $672.0K | — |